Top Banner
Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology Section of Pediatric Urology
22

Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Mar 26, 2015

Download

Documents

Bailey Whitaker
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Case Presentation: Myelomeningocele

Stephen Confer, MDBen O. Donovan, MD

Brad Kropp, MDDominic Frimberger, MD

University of Oklahoma Department of Urology

Section of Pediatric Urology

Page 2: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Case Presentation

• NICU Consultation

• HPI : 1 day old male transferred to NICU from outside facility– No prenatal history available– Identified to have myelomeningocele– Going to OR in am with Neurosurgery

Page 3: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.
Page 4: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Case Presentation

• PMHx– Denies prenatal US

– ‘Normal’ Prenatal Course

– Good Apgars

– Good amniotic fluid from birth –per report

• Social Hx– Small Town

– 21 yo Non smoker

– Denied alcohol and illicit drug usage

– Single, no children

• Medications :– ES Tylenol PRN

Page 5: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Case Presentation• Family Hx

– No malignancy

• ROSAs in HPI

Page 6: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Physical Examination

• Vitals signs : AFVSS

• General : NAD• GU: uncirc, bilateral testes descended• Abd : ND, no masses, no hepatosplenomegaly.

No inguinal hernia, umbilical stump is clear • Ext : No edema or cyanosis. MAE x 4• Back: large patch of irregular tissue at midline

Page 7: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.
Page 8: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

What would you recommend?

Page 9: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

General Recommendations

• Renal Ultrasound

• VCUG

• CIC times 3

• Baseline Urodynamics

Page 10: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Types of Myelodysplasia*

• Spina bifida occulta

• Lipomeningocele

• Meningocele

• Myelomeningocele = Spina Bifida

*defective development of the spinal cord

Page 11: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Neurologic pathologySpina bifida occulta

(occulta = closed)

A condition involving nonfusion of the halves of the vertebral arches without disturbance of the underlying neural tissue

Page 12: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Neurologic pathologyLipomeningocele

(lipo = fat)

lipoma or fatty tumor located over the lumbosacral spine. Associated with bowel & bladder dysfunction

LipomeningoceleLipomeningocele

Page 13: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Neurologic pathology

Meningocele (cele = sac)

Fluid-filled sac with meninges involved but neural tissue unaffected

Page 14: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Types of Myelodysplasia

Myelomeningocele

or spina bifida: meninges and spinal tissue protruding through a dorsal defect in the vertebrae

Page 15: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

The spinal defect with myelomeningocele

Page 16: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Incidence and Prevalence

• Incidence – 1/1000

• Prevalence – Increased incidence in families of Celtic and

Irish heritage (genetic or environmental?)– Increased incidence in minorities (genetic or

environmental?)– Increased incidence in families

Page 17: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

When do neural tube defects occur?

Page 18: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Neural Tube Development

Normal embryological development Neural plate

development -18th dayCranial closure 24th

day (upper spine)Caudal closure 26th

day (lower spine)

Page 19: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Preventive Care

• The United States Public Health Service recommends that: "All women of childbearing age in the United States who are capable of becoming pregnant should consume 0.4 mg of folic acid per day for the purpose of reducing their risk of having a pregnancy affected with spina bifida or other neural tube defects." Folic acid is a "B" vitamin that can be found in such foods as: cereals, broccoli, spinach, corn and others, and also as a vitamin supplement.

Page 20: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Clinical Considerations

What factors contribute to neural tube defects?

Page 21: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

High Risk for Renal Injury

• Increasing age, evidence of hydroureteronephrosis and vesicoureteric reflux, high leak pressures, and low bladder volume define a high risk bladder in our population and predispose to renal injury in patients of myelodysplasia.

• Early referral for bladder risk assessment and management of all myelodysplasia patients is recommended. Indian Pediatr. 2007 Jun;44(6):417-20.

Risk factors for renal injury in patients with meningomyelocele.Arora G, Narasimhan KL, Saxena AK, Kaur B, Mittal BR.

Page 22: Case Presentation: Myelomeningocele Stephen Confer, MD Ben O. Donovan, MD Brad Kropp, MD Dominic Frimberger, MD University of Oklahoma Department of Urology.

Future Directions?

Support MM Clinics & Research